What is BioLineRx Ltd. (BLRX.TA)?

BioLineRx Ltd. (BLRX.TA) is a stock in the Healthcare sector, Biotechnology industry. View full analysis on Stocks360.

BioLineRx Ltd. (BLRX.TA)

Stock analysis · TLV · Healthcare · Biotechnology

Market Cap

N/A

PE (TTM)

N/A

EPS (TTM)

N/A

Dividend Yield

N/A

Beta

0.70

Day Range

N/A

52-wk Range

N/A

Avg Volume

N/A

Volume

N/A

BioLineRx Ltd. (BLRX.TA) is a publicly traded company in the Healthcare sector. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Earnings

Most Recent

Aug 31, 2026

EPS $-0.00 vs est. $-0.00

Missed by $0.00

Proprietary Signals

Signal snapshot temporarily unavailable.

About BioLineRx Ltd.

BioLineRx Ltd., a commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel.